Artigos

UTILIZAÇÃO DE PLASMA CONVALESCENTE NO TRATAMENTO DA COVID-19

Saiba mais...

15 Julho 2021

UTILIZAÇÃO DE PLASMA CONVALESCENTE NO TRATAMENTO DA COVID-19

O plasma convalescente, que consiste em plasma com elevado teor de anticorpos contra o vírus SARS-CoV-2, obtido a partir de indivíduos recuperados da infeção, tem sido investigado no tratamento da COVID-19, com base em experiência prévia de utilização de plasma com elevado título de anticorpos noutras infeções bacterianas e virais.

Tem vindo a ser utilizado essencialmente em indivíduos hospitalizados, com COVID-19 moderada a grave. Existe, contudo, falta de consenso acerca da utilização do plasma convalescente, uma vez que os ensaios efetuados, revisões sistemáticas e meta-análises reportam resultados contraditórios, sendo incerto que aporte benefício em resultados clinicamente relevantes.

LITERATURA RECOMENDADA

Bennett-Guerrero E, Romeiser JL, Talbot LR, Ahmed T, Mamone LJ, Singh SM, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial. Crit Care Med. 2021 Jul 1; 49(7): 1015-1025. doi: 10.1097/CCM.0000000000005066.

https://journals.lww.com/ccmjournal/Fulltext/2021/07000/Severe_Acute_Respiratory_Syndrome_Coronavirus_2.2.aspx

Gharbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, et al. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nat Commun. 2021 May 27; 12(1): 3189. doi: 10.1038/s41467-021-23469-2.

https://www.nature.com/articles/s41467-021-23469-2.pdf

Lindemann M, Lenz V, Knop D, Klump H, Alt M, Aufderhorst UW, et al. Convalescent plasma treatment of critically ill intensive care COVID-19 patients. Transfusion. 2021 May; 61(5): 1394-1403. doi: 10.1111/trf.16392. Epub 2021 Apr 8. PMID: 33784412.

https://onlinelibrary.wiley.com/doi/epdf/10.1111/trf.16392

Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, Grossman BJ, Henderson JP, Musser J, Salazar E, Hartman WR, Bouvier NM, Liu STH, Pirofski LA, Baker SE, van Helmond N, Wright RS, Fairweather D, Bruno KA, Wang Z, Paneth NS, Casadevall A, Joyner MJ. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 May; 96(5): 1262-1275. doi: 10.1016/j.mayocp.2021.02.008.
harbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, et al. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nat Commun. 2021 May 27; 12(1): 3189. doi: 10.1038/s41467-021-23469-2.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888247/pdf/main.pdf

Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20; 5(5): CD013600. doi: 10.1002/14651858.CD013600.pub4.

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub4/epdf/standard

Janiaud P, Axfors C, Schmitt AM, Gloy V, Ebrahimi F, Hepprich M, Smith ER, Haber NA, Khanna N, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA. 2021 Mar 23; 325(12): 1185-1195. doi: 10.1001/jama.2021.2747.

https://jamanetwork.com/journals/jama/fullarticle/2777060

Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, et al. COVID-19 convalescent plasma: Interim recommendations from the AABB. Transfusion. 2021 Apr; 61(4): 1313-1323. doi: 10.1111/trf.16328.

https://onlinelibrary.wiley.com/doi/epdf/10.1111/trf.16328